Samuel N. Hazen - Feb 18, 2022 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
CEO, Director
Signature
/s/ Natalie Harrison Cline, Attorney-in-Fact
Stock symbol
HCA
Transactions as of
Feb 18, 2022
Transactions value $
-$8,746,103
Form type
4
Date filed
2/23/2022, 06:16 PM
Previous filing
Feb 1, 2022
Next filing
Feb 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Award $0 +85K +26.27% $0.00 409K Feb 18, 2022 Direct F1
transaction HCA Common Stock Options Exercise +6.01K +1.47% 415K Feb 18, 2022 Direct F2
transaction HCA Common Stock Tax liability -$8.75M -35.8K -8.64% $244.10 379K Feb 18, 2022 Direct
holding HCA Common Stock 813K Feb 18, 2022 By LP

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCA Restricted Stock Units Options Exercise $0 -6.01K -100% $0.00* 0 Feb 18, 2022 Common Stock 6.01K Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On January 30, 2019, the reporting person was granted 42,520 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted.
F2 Restricted stock units convert into common stock on a one-for-one basis.